Effects of pre-medication and warming device on heart rate (HR) assessed by pulse oximetry in dogs following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

Subjects:

S1 File - by Jacob P. Rastas (20642173)

Subjects:

Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group. by Jacob P. Rastas (20642173)

Subjects:

AVAcore placement. by Jacob P. Rastas (20642173)

Subjects:

Significant Lipids by Category- Tiers 1 and 2. by Keenan Elliott (17181211)

TBSS results showing significant AxD and RD changes at baseline and the follow-up. by Sewon Lim (21989785)

Subjects:

Changes in inflammatory cell count in BALF of mice exposed to continuous CS inhalation. by Yue He (385239)

Subjects:

Changes in the KEGG pathways predicted by PICRUST. by Pei P. Fu (12407203)

Subjects:

Description of fold change of MiR-125b and Lnc THRIL among study groups. by Azza Elamir (13924199)

Subjects:

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-t... by Emir Matpan (21655811)

Significant cholesterol genes arranged by day. by Katherine M. Peterson (19746455)

“…Scatter plots of the RNASeq DESeq results, P-value vs. Fold Change for each sample day, arranged chronologically. …”

Estimated short- and long-term cumulative changes in CRC incidence and CRC mortality attributable to screening, diagnosis, and treatment decreases in 2020 and 2021. by Joachim Worthington (8394213)

Subjects:

IR-induced mutation profiles of DNA repair mutants significantly different from wild-type. by Bettina Meier (274833)

Subjects:

List of 421 genes whose expression is increased by galactose and decreased by any of the HAT inhibitors. by Masaya Nagaya (13851123)

Subjects:

Number and percentage of AE patients with detectable Em2+ antibodies at different visits and significance level in binominal test. by Beate Grüner (301524)

Subjects:

Prevalence of hyperemic coronary flow decrease. by Eisuke Usui (12111855)

Subjects:

Prediction of hyperemic coronary flow decrease. by Eisuke Usui (12111855)

Subjects:

Percent viability and cytotoxicity of NHBE cells are significantly altered by PAA exposure. by Ellie S. Burns (21246537)

“…<p>(A) Viability was measured through formation of formazan crystals during the MTT assay as a metric of living cell metabolism. Percent viability significantly decreased with PAA concentration and between recovery times compared to controls. …”

The hypoxia-induced changes of endothelial and fibrotic markers. by Jing Mao (148640)

Subjects:

Significant lipids by category-Tiers 1, 2, and 3. by Keenan Elliott (17181211)